QA: Clene Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001822791_2024_Clene_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001822791, Clene Inc

  xvar xval
0 AssetsCurrent 38,852,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 13,489,000
4 LiabilitiesCurrent 25,330,000
5 LiabilitiesNoncurrent 4,903,000
6 remainder_Liabilities 8,718,000
7 CostOfGoodsAndServicesSold 121,000
8 SellingGeneralAndAdministrativeExpense 14,418,000
9 ResearchAndDevelopmentExpense 26,655,000
10 remainder_Expenses 0
11 remainder_Revenues 654,000
12 remainder_NetIncome -8,964,000
13 remainder_ComprehensiveNetIncome -4,000
  yvar yval
0 Assets 52,341,000
1 Liabilities 38,951,000
2 Expenses 41,194,000
3 Revenues 654,000
4 StockholdersEquity 13,390,000
5 NetIncome -49,504,000
6 ComprehensiveNetIncome -49,506,000
7 BaseVar 71,054,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.445
9 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time